Stockreport

Gain Therapeutics Announces 2024 R&D Update on Parkinson's Disease with KOL & Analyst Insight [Yahoo! Finance]

Gain Therapeutics, Inc.  (GANX) 
PDF BETHESDA, Md., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc., (Nasdaq: GANX), a clinical-stage biotechnology company leading the discovery and development o [Read more]